Elena Aguirre, Teresa Taberner, Armando Luaña, Serafin Morales, Antonio Llombart
Department of Oncology, Hospital Arnau de Vilanova, Lérida, Spain. elenaaguirreortega@yahoo.es
Tumori 2013 Jan-FebDrug-induced immune thrombocytopenia may occur secondary to several chemotherapeutic agents or new targeted monoclonal antibodies, but thrombocytopenia induced by trastuzumab is a very rare occurrence. We report a case of severe thrombocytopenia related to the administration of trastuzumab six months after the first exposure.
Elena Aguirre, Teresa Taberner, Armando Luaña, Serafin Morales, Antonio Llombart. Severe thrombocytopenia related to long-term trastuzumab exposure. Tumori. 2013 Jan-Feb;99(1):e1-2
PMID: 23549016
View Full Text